Korean J Pediatr.
2010 Jan;53(1):93-96. 10.3345/kjp.2010.53.1.93.
The effect of perioperative inhaled iloprost on congenital heart disease with severe pulmonary arterial hypertension
- Affiliations
-
- 1Department of Pediatrics, Gil Hospital, Gachon University of Medicine, Incheon, Korea. pskcdy@gilhospital.com
- KMID: 1837788
- DOI: http://doi.org/10.3345/kjp.2010.53.1.93
Abstract
- A 47-year-old male patient in whom atrial septal defect (ASD) had been diagnosed 15 years previously was admitted for cardiac catheterization. He had definite cyanotic lips and nail beds and severe pulmonary arterial hypertension (PAH). He had received medical treatment only for the last few years after being diagnosed with Eisenmenger syndrome. After cardiac catheterization, he received iloprost inhalation therapy pre and postoperation and was discharged after successful surgical closure of the ASD.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Pulmonary Arterial Hypertension is Normalized Following Six Years of Inhaled Iloprost Treatment in a Patient with Systemic Sclerosis
- The Therapeutic Effect of Inhaled Iloprost in Newborn Infants with Severe Persistent Pulmonary Hypertension Refractory to Inhaled Nitric Oxide
- Inhaled Nitric Oxide as a Therapy for Pulmonary Hypertension after Operations for Congenital Heart Diseases
- A case of persistent pulmonary hypertension of the newborn: Treatment with inhaled iloprost
- Diagnosis and treatment of idiopathic pulmonary arterial hypertension
